Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06229470 · ClinicalTrials.gov registry record · NA

Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain

A NA study of Chronic Pain, sponsored by Saluda Medical Pty.

Active
Registry status
NA
Development phase
250
Enrollment target
20
Study locations

NCT06229470: Active NA study of Chronic Pain, sponsored by Saluda Medical Pty.

NCT06229470 is a NA study of Chronic Pain that is active but no longer recruiting, run by Saluda Medical Pty. The registered enrollment target is 250 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (68% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06229470, a NA study of Chronic Pain, is active but no longer recruiting, sponsored by Saluda Medical Pty.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the clinical utility of neurophysiological measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide treatment of chronic pain of the trunk and/or limbs.

Primary Outcome

physiological parameter to be measured = Evoked Compound Action Potentials (ECAPs); measurement tool = Evoke SCS System

Conditions Studied

Interventions

  • DEVICE Evoke Spinal Cord Stimulation (SCS) System

Study Locations (20)

California

  • Spanish Hills Interventional Pain Specialists - Camarillo
  • Pain Consultants of San Diego - La Mesa
  • Pacific Research Institute - Santa Rosa
  • Boomerang Healthcare - Walnut Creek

Michigan

  • Michigan Pain Specialists - Ann Arbor
  • Pain Clinic of Michigan - Rochester Hills

Arizona

  • Lakeside Spine and Pain - Lake Havasu City

Colorado

  • DBPS Research - Greenwood Village

Florida

  • Pohlman Pain Associates - Delray Beach

Georgia

  • Horizon Clinical Research - Jasper

Illinois

  • Rockford Pain Center - Rockford

Indiana

  • Goodman Campbell Brain and Spine - Carmel

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-08
Est. Completion 2027-02-28
Phase NA
Saluda Medical Pty

4 total trials

What the registry record for NCT06229470 still lists

NCT06229470 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (68% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Evoke Spinal Cord Stimulation (SCS) System is the first listed.

NCT06229470 names 20 study sites across 16 states, led by California, Michigan, Arizona.

Frequently Asked Questions

What is clinical trial NCT06229470 about?

NCT06229470 is a clinical study titled "Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain". The purpose of this study is to evaluate the clinical utility of neurophysiological measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide treatment of chronic pain of the trunk and/or limbs.

What is the current status of trial NCT06229470?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-08. Estimated completion is 2027-02-28.

What conditions does trial NCT06229470 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06229470?

The interventions under investigation include: Evoke Spinal Cord Stimulation (SCS) System (DEVICE).

Who is sponsoring clinical trial NCT06229470?

This trial is sponsored by Saluda Medical Pty, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06229470 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06229470's enrollment target sits among peer trials

250 66th of 301 higher than 236 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06229470, the US trial registry maintained by the National Library of Medicine. NCT06229470 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.